Indian Big Four Snake Venom Toxins (Three-Finger Toxins, Phospholipase A2, and Snake Venom Metalloproteinases) (Big Four Venom Toxins)

The Big Four snake venom toxins represent the primary toxic components from the four most medically significant snakes in India: the Indian Cobra (Naja naja), Common Krait (Bungarus caeruleus), Russell’s Viper (Daboia russelii), and Saw-scaled Viper (Echis carinatus) [18, 24]. These venoms are characterized by a high abundance of Three-Finger Toxins (3FTx), Phospholipase A2 (PLA2), and Snake Venom Metalloproteinases (SVMP) [16, 19, 25]. 3FTxs and PLA2s are primarily responsible for neurotoxic effects, such as neuromuscular blockade and respiratory paralysis, as well as myotoxicity [14, 16, 19]. SVMPs and certain PLA2s drive hemotoxic effects, including systemic hemorrhage, local tissue damage, and consumption coagulopathy [4, 19]. Envenomation by these species is a major public health crisis in South Asia, leading to tens of thousands of deaths and permanent disabilities annually [18, 20]. While polyvalent antivenom remains the standard of care by neutralizing these toxins through antibody binding, its use is often limited by risks of anaphylaxis and the need for cold-chain storage [8, 10, 19]. Consequently, small-molecule inhibitors like varespladib and marimastat are being investigated as potential field-deployable adjuncts to specifically inhibit the enzymatic activities of PLA2 and SVMP, respectively [2, 3, 7].

Other names

Indian Big Four venomNaja naja, Bungarus caeruleus, Daboia russelii, and Echis carinatus venom toxinsBig Four snakebite toxinsIndian cobra, common krait, Russell’s viper, and saw-scaled viper venom

Antibody-mediated neutralization of venom components; competitive inhibition of Phospholipase A2 (PLA2) enzymatic activity; zinc-dependent inhibition and chelation of Snake Venom Metalloproteinases (SVMP).